Analytical apparatus and analytical method
The two-step method of membrane filtration and flushing, integrated with a flow injection system, addresses the challenges of detecting low endotoxin concentrations by ensuring complete recovery and maintaining membrane integrity, enhancing detection accuracy and reducing reagent use.
Patent Information
- Application Number
- JP2025077096
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-07
- Publication Date
- 2026-11-19
- Estimated Expiration
- 2045-05-07
AI Technical Summary
Existing methods for detecting low concentrations of endotoxins in pharmaceutical water and drug manufacturing processes face challenges in achieving high accuracy and sensitivity due to adherence of endotoxins to filtration membranes, leading to reduced detection efficiency and membrane lifespan, and potential reactivity issues with alkaline backwashing.
A two-step method involving membrane filtration for concentration and flushing of endotoxins, combined with a flow injection system for analysis, using a reagent to enhance detection accuracy by ensuring complete recovery of endotoxins from the membrane surface.
Enables high-precision analysis of low concentrations of endotoxins with reduced reagent consumption, maintaining membrane integrity and extending its lifespan by effectively flushing adhered endotoxins during analysis.
Smart Images

Figure 2026181643000001_ABST
Abstract
Description
[Technical Field]
[0001] The present invention relates to an analytical apparatus and an analytical method. [Background technology]
[0002] Endotoxins (ETs) are microbial contaminants that require strict control in pharmaceutical water and drug manufacturing processes. They must be removed as much as possible, and online monitoring is essential. Traditionally, the Limulus test has been primarily used for endotoxin detection, but real-time online analysis has been difficult with this method.
[0003] Patent Document 1 describes a flow injection analysis (FIA) method in which a liquid-liquid mixture consisting of an organic phase and an aqueous phase is introduced into the inner tube of a double tube consisting of a porous polymer membrane inner tube and an outer tube enclosing the inner tube, or into a region surrounded by the inner and outer tubes, and only the organic phase is allowed to permeate through the wall of the porous polymer membrane inner tube to separate the organic phase from the aqueous phase, and the obtained organic phase is introduced into a detection unit to analyze the element to be tested. However, this method has been criticized for its variability in the reaction efficiency of the reagents and the accuracy of the measurement, and in particular for its insufficient detection sensitivity when detecting low concentrations of endotoxin.
[0004] Therefore, the inventors developed a method for detecting endotoxins online using flow injection analysis, employing a fluorescent reagent that specifically recognizes endotoxins and functions as a fluorescent label by binding to endotoxins (see, for example, Patent Document 2). Furthermore, they developed an analytical apparatus that enhances the quantitative accuracy of the analysis by concentrating endotoxins by cross-flow filtration of analyte water containing endotoxins at low concentrations using an ultrafiltration membrane (see, for example, Patent Document 3). In addition, a technique has been proposed in which a liquid is completely filtered using a filtration membrane to accumulate the particles on the membrane surface, and then recovered by backwashing, for example, to detect fine particles in a liquid (see, for example, Patent Document 4). In this technique, fine particles in the liquid are accumulated on the membrane surface by performing total filtration at a high flow rate using a large-area ultrafiltration membrane, and then the accumulated fine particles are detached from the membrane surface by backwashing the filtration membrane with alkaline functional water, and then recovered with a filtration membrane for capturing fine particles. [Prior art documents] [Patent Documents]
[0005] [Patent Document 1] Japanese Patent Application Publication No. 62-280652 [Patent Document 2] Japanese Patent Publication No. 2022-011525 [Patent Document 3] Patent No. 7606197 [Patent Document 4] Japanese Patent Publication No. 2025-032796 [Overview of the Initiative] [Problems that the invention aims to solve]
[0006] However, the lower the concentration of endotoxin, the higher the concentration required, and therefore, a large flow rate ratio of permeate water to concentrated water is necessary to achieve sufficient concentration. The inventors have found that in the analysis of such low concentrations of endotoxin, a reduction in the amount of concentrated water causes the endotoxin to adhere to the filtration membrane and become difficult to flush out. In particular, during long periods of continuous operation, there was a concern that the recovery of endotoxin adhering to and accumulating on the membrane surface would be insufficient, not only reducing the accuracy of endotoxin detection but also shortening the lifespan of the filtration membrane. Furthermore, when the technology described in Patent Document 4 is applied to the analysis of endotoxin, there was a concern that recovery would be insufficient even by backwashing. In addition, the alkaline functional water used in backwashing may affect the physical properties of the endotoxin being detected, affecting its reactivity with the reagent and potentially making highly sensitive analysis difficult.
[0007] The present invention has been made to solve the above-mentioned problems and provides an analytical method and analytical apparatus that can detect analytes such as low concentrations of endotoxins with high accuracy. [Means for solving the problem]
[0008] To solve these problems, the inventors have found a two-step method: a concentration step in which endotoxins are concentrated in a membrane filtration device by membrane filtration, and an analysis step in which the concentrated endotoxins are sent to an analyzer for analysis. First, in the concentration step, the entire volume of the analyte is filtered to accumulate endotoxins in the membrane filtration device. Next, in the analysis step, the accumulated endotoxins are flushed out of the membrane filtration device. By combining accumulation and flushing in this way, endotoxins attached to the filtration membrane can be flushed out of the membrane filtration device, making it possible to measure highly concentrated analytes with high accuracy.
[0009] The present invention was made based on the above-described studies, and embodiments of the present invention have the following configurations. [1] A flow injection system for analyzing the analyte by reacting the analyte with a reagent in water and using the resulting reaction product, A membrane filtration apparatus equipped with a microfiltration membrane or an ultrafiltration membrane, A concentration mechanism for accumulating the analyte in the water within the membrane filtration device, A flushing mechanism that flows the analyte accumulated in the membrane filtration device together with the concentrated water from the membrane filtration device into the flow injection system, A switching mechanism for switching between the concentration mechanism and the flushing mechanism, A reagent injection unit that supplies the reagent to the flow injection system and An analytical apparatus characterized by having the following features. [2] The analytical apparatus according to [1], wherein the concentration mechanism is performed by total filtration with the membrane filtration device. [3] The analytical apparatus according to [1], wherein the flushing mechanism flows the entire amount of the supply water from the membrane filtration device to the flow injection system from the concentration side. [4] The analytical apparatus according to [1], wherein the flushing mechanism flows 50% or more of the supply water of the membrane filtration device as concentrated water into the flow injection system. [5] The reagent injection unit is the analytical apparatus according to [4], wherein the reagent injection unit injects the reagent into the reagent line. [6] The analytical apparatus according to [1], wherein the flushing mechanism is a backwashing mechanism that supplies water from the permeate side of the membrane filtration apparatus and discharges the analyte from the concentration side of the membrane filtration apparatus. [7] The flow injection system is an analytical apparatus according to any one of [1] to [6] that is capable of quantitatively analyzing the target of analysis. [8] In an analytical method for analyzing an analyte by reacting the analyte with a reagent in water to produce a reaction product, A concentration step in which the analyte is accumulated on a filtration membrane using one or more filtration membranes selected from microfiltration membranes and ultrafiltration membranes, An analysis method, comprising an analysis step of flowing the reagent into the flow injection system while flowing the accumulated analysis target into the flow injection system together with the concentrated water of the filtration membrane. [9] The analysis method according to [8], wherein in the concentration step, full-volume filtration is performed with the filtration membrane.
[10] The analysis method according to [8], wherein the reagent is caused to flow into the flow injection system together with the permeated water of the filtration membrane.
[11] The analysis method according to [8], wherein in the analysis step, the entire amount of feed water to the filtration membrane is caused to flow into the flow injection system as the concentrated water.
[12] The analysis method according to any one of [8] to
[11] , wherein the analysis method is capable of quantitatively analyzing the analysis target. The symbol "~" indicates a numerical range including the numerical values before and after the symbol. [Effects of the Invention]
[0010] According to the analysis apparatus and analysis method of the present invention, it is possible to measure an analysis target with high accuracy. [Brief Description of the Drawings]
[0011] [Figure 1] It is a diagram illustrating an analysis apparatus according to an embodiment of the present invention. [Figure 2] It is a diagram illustrating an analysis apparatus according to another embodiment of the present invention. [Figure 3] It is a diagram illustrating an analysis apparatus according to another embodiment of the present invention. [Figure 4] It is a diagram illustrating an analysis apparatus according to another embodiment of the present invention. [Figure 5] It is a diagram illustrating an analysis apparatus according to another embodiment of the present invention. [Figure 6] It is a diagram illustrating an analysis apparatus according to another embodiment of the present invention. [Figure 7] It is a graph schematically showing concentration changes of concentrated water measured by the analysis apparatus of the present invention and an analysis apparatus in the related art. [Modes for Carrying Out the Invention]
[0012] Embodiments of the present invention will be described below with reference to the drawings.
[0013] Figure 1 shows an analytical apparatus 12 according to an embodiment of the present invention. The analytical apparatus 12 shown in Figure 1 analyzes microbial substances and fungi (live bacteria themselves) contained in the water to be analyzed. That is, the analytical apparatus 12 of this embodiment can detect the analyte in the water to be analyzed (qualitative analysis) or measure the concentration of the analyte in the water to be analyzed (quantitative analysis). The microbial substance is, for example, endotoxin, which is a lipopolysaccharide that constitutes the cell wall of Gram-negative bacteria.
[0014] Examples of water to be analyzed include pharmaceutical water such as water for injection (WFI) and purified water, and semiconductor manufacturing water such as pure water and ultrapure water. The water to be analyzed may also be water collected during the manufacturing process of the above-mentioned pharmaceutical water or semiconductor water. The water to be analyzed can be collected from a water treatment system. Examples of water treatment systems include a purified water production system, a water for injection production system, and a pure water production system or ultrapure water production system for semiconductor water.
[0015] The analytical apparatus 12 according to this embodiment includes a concentration mechanism for concentrating the analyte and an analytical mechanism (flushing mechanism) for analyzing the concentrated analyte. The analytical apparatus 12 further includes a switching mechanism for switching between the concentration mechanism and the analytical mechanism. For example, the concentration mechanism and the analytical mechanism consist of one or more valves that can be opened and closed, and one or more pipes that constitute the flow paths for the analyte water and the flushing water. The switching mechanism is, for example, a control device that switches the flow paths by controlling the opening and closing of each valve, and the concentration mechanism and the analytical mechanism can be switched by this control device.
[0016] The analyzer 12 comprises a pre-concentration pump 14, a membrane filtration device 16, and piping 18 connected to the inlet side of the membrane filtration device 16. The pre-concentration pump 14 is located in the path of the piping 18, and the water to be analyzed (supply water) is sent from the water treatment system to the pump 14. Here, supply water refers to the water to be analyzed supplied to the membrane filtration device 16. The pre-concentration pump 14 pressurizes the water to be analyzed. The pressurized water to be analyzed is sent through the piping 18 to the downstream membrane filtration device 16. For example, when the analyzer 12 is directly attached to the sampling line of a purified water production system or an ultrapure water production system for online analysis, the pre-concentration pump 14 can be omitted if the pressure in the sampling line is appropriate for sending the water to the downstream stage. Also, if the pressure in the sampling line is too high compared to the appropriate pressure, a pressure reducing means such as a pressure reducing valve can be installed instead of the pre-concentration pump 14. The analyzer 12 can measure the analyte online or offline, and online measurement is preferred.
[0017] The membrane filtration apparatus 16 has an outer cylinder 20. Inside the outer cylinder 20, an ultrafiltration membrane 30 or a microfiltration membrane is arranged. The pore size of the ultrafiltration membrane 30 is large enough to capture bacterial-derived substances as the analyte, and the molecular weight cutoff is generally 1 kDa to 100 kDa. The pore size of the microfiltration membrane is large enough to capture fungi as the analyte, and is generally 0.1 μm to 0.5 μm. A microfiltration membrane may be used instead of an ultrafiltration membrane. As the ultrafiltration membrane or microfiltration membrane, a membrane that removes 90% or more of the analyte is more preferable, and a membrane that removes 95% or more is even more preferable.
[0018] The material for the ultrafiltration membrane 30 can be any material used for ultrafiltration membranes, such as cellulose acetate, polyacrylonitrile, polysulfone, polyethersulfone, modified polyethersulfone, polyvinylidene fluoride, etc. Polyacrylonitrile, polysulfone, polyethersulfone, modified polyethersulfone, and polyvinylidene fluoride are preferred as materials for the ultrafiltration membrane 30. Among these, modified polyethersulfone is particularly preferred as the material for the ultrafiltration membrane. Because modified polyethersulfone has high hydrophilicity, fine particles adsorbed onto the membrane surface of the ultrafiltration membrane 30 are easily detached. Therefore, it is preferable because the fine particles accumulated in the concentration step described later can be easily discharged from the ultrafiltration membrane 30 in the subsequent analysis step. The pore size of the ultrafiltration membrane 30 used in the filtration device 16 is large enough to capture fine particles; for example, the molecular weight cutoff is preferably in the range of 1 kDa to 100 kDa. The shape of the ultrafiltration membrane 30 is usually hollow fiber. The effective membrane area of the ultrafiltration membrane 30 is 100 mm². 2 Above 1000mm 2 The following range is preferable. This makes it easier to measure the endotoxin concentration in relatively small amounts of supply water, as described later. Although the reason is not clear, endotoxins tend to detach easily from the UF membrane (ultrafiltration membrane). One possible reason for this phenomenon is that while fine particles are nearly spherical and have a uniform charge on their surface, endotoxins have an elongated shape and show charge unevenness at both ends.
[0019] A commercially available membrane filtration device 16 can be used. Examples of commercially available products using ultrafiltration membranes include Repligen's MIDIKROS (trade name) MPES (modified polyethersulfone).
[0020] An inlet 22 is provided at one end of the outer cylinder 20 of the membrane filtration device 16 in the longitudinal direction, and an outlet 24 is provided at the other end. Furthermore, a discharge section 26 is provided on the outer circumference of the outer cylinder 20. Piping 18 is connected to the inlet 22. A first pipe 32 is connected to the outlet 24. One end of a discharge pipe 31 is connected to the discharge section 26. A second valve 62 is provided on the discharge pipe 31. A first valve 60 is provided in the path of the first pipe 32, and furthermore, a flow injection system 40 is connected to the downstream side of the first valve 60 of the first pipe 32.
[0021] In the membrane filtration apparatus 16, the outlet 24 is provided on the concentration side of the ultrafiltration membrane 30, and the concentrated water from the ultrafiltration membrane 30 is sent from the outlet 24 to the first pipe 32. The discharge 26 is provided on the permeate side of the ultrafiltration membrane 30, and the permeate water from the ultrafiltration membrane 30 is sent to the discharge 26.
[0022] With these configurations, the concentrated water from the membrane filtration device 16 is sent to the flow injection system 40 as sample water through the first pipe 32.
[0023] The flow injection system 40 has a sample water line and a reagent line, and a pump provided within the flow injection system 40 mixes the sample water and reagent by synchronizing the supply from the sample water line and the reagent line. The first pipe 32 that carries the sample water constitutes the sample water line. The flow injection system 40 is connected to a second pipe 34 for supplying reagents to the flow injection system 40, and the second pipe 34 constitutes the reagent line. A reagent injection unit 44 that injects reagents into the second pipe 34 is connected to the second pipe 34. The reagent injection unit 44 consists of, for example, a chemical injection pump that quantifies and delivers the reagent, and a pipe that supplies the reagent delivered by the chemical injection pump to the second pipe 34. Alternatively, a loop pipe 70 that bypasses the connection between the reagent injection unit 44 and the second pipe 34 may be connected between the reagent injection unit 44 and the second pipe 34, allowing switching between a direct flow path from the reagent injection unit 44 to the second pipe 34 and a flow path from the reagent injection unit 44 to the second pipe 34 via the loop pipe 70. By sending the reagent injected into the reagent injection unit 44 to the second pipe 34 via the loop tube 70, the time it takes for the reagent to reach the flow injection system 40 can be delayed compared to when the reagent is injected directly from the reagent injection unit 44 to the second pipe 34. The amount of reagent supplied to the flow injection system 40 can be adjusted by adjusting the length of the loop tube 70.
[0024] The timing of reagent injection may be controlled by the reagent injection unit 44. For example, by considering the change in the concentration of the analyte in the sample water flowing through the analyzer 48 when analysis is performed, and controlling the injection of the reagent at the timing when the concentration of endotoxin in the concentrated water is at its maximum (endotoxin concentration peak), high analytical accuracy can be achieved while suppressing reagent consumption. Alternatively, the timing of reagent injection may be controlled by adjusting the length of the loop tube 70 so that the reagent is supplied between the rise of the endotoxin concentration peak and the convergence of the peak. Reagent injection may also be controlled by program control.
[0025] With this configuration, the reagent injected from the reagent injection unit 44 into the second pipe 34 is sent to the flow injection system 40. Then, the reaction product produced by the reaction between the sample water and the reagent in the flow injection system 40 is measured by a measuring instrument in the flow injection system 40, thereby analyzing the target substance.
[0026] The analytical apparatus 12 of this embodiment includes a bypass pipe 80 connecting the path of the first pipe 32 and the path of the second pipe 34. The bypass pipe 80 is equipped with a third valve 64. Alternatively, a three-way valve may be provided at the connection between the first pipe 32 and the bypass pipe 80 instead of the first valve 60 and the third valve 64. Furthermore, the first valve 60, the second valve 62, and the third valve 64 may be variable-opening valves or on / off valves, and their opening or closing or opening degree may be automatically controlled by a control device or the like. The same applies to the other valves described later. Each valve may also be a multi-way valve. If a multi-way valve is used, it is possible to group multiple valves that are in close proximity together.
[0027] Next, an analytical method using the analytical device 12 will be described. The analytical method of this embodiment includes a concentration step and an analytical step. First, in the concentration process, the second valve 62 is opened, the first valve 60 is closed, and the third valve 64 is opened. Then, the water to be analyzed is supplied to the membrane filtration device 16 via the piping 18 by the pre-concentration pump 14. In addition, ultrapure water (or water for injection, the same applies hereinafter) is supplied to the second piping 34.
[0028] As a result, the water to be analyzed is completely filtered by the membrane filtration device 16, and the analytes contained in the water are accumulated in the membrane filtration device 16. The permeate from the membrane filtration device 16 is discharged out of the system via the discharge pipe 31. During this time, the injection of reagents from the reagent injection unit 44 is stopped. As a result, the ultrapure water supplied to the second pipe 34 is supplied to the flow injection system 40 via the second pipe 34, the bypass pipe 80, and the first pipe 32. At this time, the flow path of the water to be analyzed, formed by the open second valve 62, the closed first valve 60, and the open third valve 64, constitutes the concentration mechanism. In the concentration process, when ultrapure water is supplied to the second pipe 34, the ultrapure water is sent to the flow injection system 40 from the bypass pipe 80 through the first pipe 32. Normally, the flow injection system 40 requires a start-up operation to flow the solvent before starting the measurement, but by flowing ultrapure water into the flow injection system 40 during the concentration process, the analysis process can be performed immediately after the concentration process without going through the start-up operation. In the concentration process, the flow rate of the concentrated water in the membrane filtration device 16 is preferably 3% or less of the flow rate of the supply water, more preferably 1% or less, and the concentration process is even more preferably a total filtration process in which the concentrated water is not discharged. In the storage process, total filtration allows for more accurate measurement of the concentration of the analyte, but if the flow rate of the concentrated water is within the above preferred range, it is possible to measure the concentration of the analyte as accurately as in the case of total filtration.
[0029] In the concentration process, the supply flow rate of the ultrapure water to be measured is preferably 10 mL / min or more and 500 mL / min or less. A more preferable range is 50 mL / min or more and 400 mL / min or less. An even more preferable range is 100 mL / min or more and 300 mL / min or less. The analyzer 12 of this embodiment is suitable for measurement at relatively low flow rates as described above, and in this case, it tends to exhibit excellent results. Furthermore, the supply flux is preferably 0.1 mm / min or more and 55 mm / min or less. A more preferable flux is 0.5 mm / min or more and 40 mm / min or less. An even more preferable flux is 1 mm / min or more and 35 mm / min or less.
[0030] By performing a concentration process for a predetermined period, the analytes in the water to be analyzed that have passed through the membrane filtration device 16 during that period accumulate within the membrane filtration device 16. Subsequently, the analysis process is performed. In the analysis process, with the water to be analyzed and ultrapure water being supplied to the analyzer 12, the second valve 62 is closed, the first valve 60 is opened, and the third valve 64 is closed. As a result, the analyte accumulated in the membrane filtration device 16 during the concentration process is pushed out by the newly supplied water to be analyzed and sent to the flow injection system 40 as sample water via the first pipe 32. At the same time, the reagent injection unit 44 is activated to supply the reagent into the second pipe 34. This supplies ultrapure water containing the reagent as carrier water into the flow injection system 40. The analyte is then analyzed by measuring the reaction product produced by the reaction between the sample water and the reagent in the flow injection system 40 using a measuring instrument in the flow injection system 40. At this time, the flow path of the water to be analyzed, formed by the closed second valve 62, the open first valve 60, and the closed third valve 64, constitutes the flushing mechanism.
[0031] Preferably, the flow rate of the water to be analyzed through the first pipe 32 in the analysis process is 50% to 100% of the supply flow rate of the water to be analyzed to the membrane filtration device 16. By having a flow rate of the water to be analyzed through the first pipe 32 in the analysis process that is 50% or more of the supply flow rate of the water to be analyzed to the membrane filtration device 16, the water can be supplied to the flow injection system 40 without leaving any of the water accumulated in the membrane filtration device 16 behind. By having a flow rate of the water to be analyzed through the first pipe 32 in the analysis process that is 100% or less of the supply flow rate of the water to the membrane filtration device 16, the water can be supplied to the flow injection system 40 without the water accumulated in the membrane filtration device 16 being mixed with the newly supplied water to be analyzed, thereby improving the accuracy of quantitative analysis. Furthermore, the supply flow rate to the membrane filtration device can be varied between the concentration process and the analysis process. In this embodiment, by closing valve 62 during the analysis process, the flow rate of permeate (discharge side) is made virtually zero, or by backwashing with water that does not affect the analytical equipment, such as pure water, the majority of the endotoxins concentrated on the membrane surface can be flushed to the measurement side.
[0032] Furthermore, it is preferable that the flow rate of the water to be analyzed supplied to the membrane filtration device 16 in the analysis process is 50% to 300% of the flow rate of the water to be analyzed supplied in the concentration process. By having a flow rate of 50% or more of the water to be analyzed supplied in the analysis process, the analytes accumulated in the membrane filtration device 16 can be flowed to the flow injection system 40 without leaving any residue. By having a flow rate of 300% or less of the water to be analyzed supplied in the analysis process, the analytes accumulated in the membrane filtration device 16 can be flowed to the flow injection system 40 without being mixed with the newly supplied water to be analyzed, thereby improving the accuracy of quantitative analysis.
[0033] The flow rate of the water to be analyzed can be adjusted by the discharge pressure of the pre-concentration pump 14. Alternatively, the flow rate may be temporarily increased at the start of flushing (the start of the analysis process) to promote the removal of endotoxins accumulated on the surface of the ultrafiltration membrane 30.
[0034] The volume of water to be analyzed supplied to the membrane filtration device 16 in the concentration and analysis steps, as well as the time for each step, may be adjusted according to the expected concentration of the analyte or the height of the concentration peak measured by the analyzer 48 in the analysis step. For example, if the endotoxin concentration is low, the concentration step may be set to a longer duration, and if the endotoxin concentration is high, the concentration step may be set to a shorter duration. These may also be automatically adjusted by controlling the valves using the control device described above. Furthermore, the amount and timing of reagent input may be appropriately adjusted according to changes in the expected concentration of the analyte or the height of the peak concentration. This optimizes the efficiency of reagent use and improves analytical accuracy.
[0035] In the analysis method using the analyzer 12, the analyte in a predetermined amount of water to be analyzed is concentrated in the concentration step, and then the concentrated water containing a high concentration of the analyte can be flowed into the flow injection system 40 as sample water. Therefore, low concentrations of the analyte can be analyzed with high accuracy. In addition, by timing the injection of reagents from the reagent injection unit 44 to coincide with the flow of the concentrated sample water containing the analyte during the analysis step, the amount of reagent used can be reduced.
[0036] The endotoxin concentration to be measured in this embodiment is preferably 0.001 EU / mL or more and 1 EU / mL or less. When adsorbed or captured on the membrane surface in a highly dispersed state, it can be easily detached from the membrane surface. The endotoxin concentration is 10 10 The concentration of particles / mL or less makes it easier to maintain high dispersion in water, and in this highly dispersed state, it accumulates within the ultrafiltration membrane 30 during the accumulation process. Furthermore, the amount of endotoxin adsorbed onto the membrane at this time is 8.3 × 10⁻⁶ per unit area. -13 g / cm 2 ~8×10 ―6 g / cm 2 This is the result.
[0037] As described above, the analytical apparatus 12 according to this embodiment combines a concentration process and an analysis process, thereby supplying concentrated sample water of the analyte to the flow injection system 40, and enabling high-precision analysis of the analyte. Furthermore, it allows for the analysis of low concentrations of the analyte while reducing the amount of reagent used.
[0038] Furthermore, the analytical apparatus 12 according to this embodiment is capable of alternately executing the concentration process and the analysis process at predetermined time intervals or according to measurement conditions. Therefore, continuous measurement becomes possible by measuring the analyte concentrated in the concentration process with high precision in the analysis process, and then returning to the concentration process. The time interval at which the processes are switched may be adjusted as appropriate according to changes in the measurement results. These process switching operations can be performed by controlling operations such as valve opening and closing and pump control using a switching mechanism.
[0039] Next, the flow injection system 40 will be described. The flow injection system 40 includes a pump 42 provided in common or separately to the first pipe 32 and the second pipe 34, a confluence pipe 46 that merges the first pipe 32 and the second pipe 34 downstream of the pump 42, and an analyzer 48 connected to the confluence pipe 46. The sample water and reagent that have passed through the pump 42 are mixed in the confluence pipe 46. This causes the analyte in the sample water to react with the reagent in the carrier water. The reaction product of the analyte and reagent is then sent to the analyzer 48. Since the amounts of the analyte and the reaction product are correlated, the concentration of the analyte is measured by the analyzer 48 measuring the reaction product.
[0040] Pump 42 is, for example, a plunger pump. In this plunger pump, a plunger reciprocates within the pump housing to pressurize the fluid and send it from the upstream side to the downstream side. Preferably, pump 42 is a double plunger pump having two plungers arranged in parallel. The double plunger pump is provided in common to the first piping 32 and the second piping 34. Pump 42 is capable of sending the sample water and carrier water downstream in sync with their pressurization cycles. Pump 42 may also be a peristaltic pump, a syringe pump, or a solenoid pump. It is more preferable that pump 42 is a plunger pump.
[0041] When the target of analysis is endotoxin, a fluorescent reagent described in Japanese Patent Publication No. 2022-011525, in which the fluorescent site and the recognition site are linked by a spacer, can be used as the reagent, but is not limited to this. The fluorescent reagent is activated by the reaction of endotoxin with the above-mentioned fluorescent reagent. Inside the analyzer 48, there are pipes (not shown) and a quartz cell connected to the pipes. The analyzer 48 irradiates light onto the combined water flowing through the quartz cell. As a result, the activated reagent emits fluorescence, and the analyzer 48 can measure the concentration of endotoxin from the signal intensity of this fluorescence. The analyzer 48 has an outlet pipe 50 for discharging the combined water after analysis.
[0042] In the analyzer 48, for example, excitation light with a wavelength of 340 to 360 nm is irradiated, and the activated reagent is quantified by observing the resulting fluorescence at 440 to 520 nm. In the analyzer 48, a sample water flow rate of 0.01 to 4.00 mL / min is preferable for improving measurement accuracy.
[0043] The materials of the first pipe 32, the second pipe 34, and the junction pipe 46 are not limited as long as they can carry the sample water, carrier water, and junction water, respectively. The material of the piping for the analyzer 48 is not particularly limited, but for example, fused silica tubing is used. Because fused silica tubing has extremely low reactivity with activated reagents, using fused silica tubing enables more accurate endotoxin analysis.
[0044] Figure 2 shows an analytical apparatus 121 of another embodiment of the present invention. In the analytical apparatus 121, reagents are continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. As shown in Figure 2, the analytical apparatus 121 has an ultrapure water pipe 82 connected to the first pipe 32 instead of the bypass pipe 80 of the analytical apparatus 12 shown in Figure 1, and a third valve 64 is provided in the ultrapure water pipe 82. As a result, in the concentration process, the third valve 64 is opened to send ultrapure water to the flow injection system 40 through the ultrapure water pipe 82. In the analysis process, by closing the third valve 64 and stopping the supply of ultrapure water, only the sample water can be supplied to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, reagents are continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the second pipe 34, making it possible to mix the reagents with the sample water.
[0045] Next, with reference to Figure 3, a case in which the permeate from the membrane filtration device 16 is used as carrier water will be described. Figure 3 is a diagram showing an analyzer 122 of another embodiment of the present invention. In the analyzer 122, a discharge section 26 and a water supply section 28 are provided on the outer circumference of the outer cylinder 20 of the membrane filtration device 16. A third pipe 36 is connected to the water supply section 28. The opposite side of the third pipe 36 from the water supply section 28 is connected to a pump 42 of the flow injection system 40. Similar to the second pipe 34 of the analyzer 12 shown in Figure 1, a reagent injection section 44 for injecting reagents into the third pipe 36 is connected to the third pipe 36. A loop pipe 70 that bypasses the connection between the reagent injection section 44 and the third pipe 36 may be connected between the reagent injection section 44 and the third pipe 36.
[0046] In the analytical apparatus 122 shown in Figure 3, during the concentration process, the second valve 62 is opened and its opening is reduced. The first valve 60 is closed, and the third valve 64 is opened. Then, the water to be analyzed is supplied to the membrane filtration apparatus 16 via the piping 18 by the pre-concentration pump 14.
[0047] As a result, the water to be analyzed is completely filtered by the membrane filtration device 16, and the analytes contained in the water are accumulated within the membrane filtration device 16. A portion of the permeate from the membrane filtration device 16 is discharged out of the system via the discharge pipe 31, and the remainder is sent to the flow injection system 40 via the third pipe 36. During this time, the injection of reagents from the reagent injection unit 44 is stopped. As a result, the permeate supplied to the third pipe 36 is supplied to the flow injection system 40 via the third pipe 36, the bypass pipe 80, and the first pipe 32. At this time, the flow path of the water to be analyzed, formed by the second valve 62 with its opening degree adjusted, the first valve 60 closed, and the third valve 64 open, constitutes the concentration mechanism.
[0048] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the third pipe 36 may be connected upstream of the second valve 62 of the discharge pipe 31, thereby sending a portion of the permeate from the concentration process to the third pipe 36 and flowing it into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the discharge pipe 31 may be connected upstream of the reagent injection unit 44 of the pipe 36 via the second valve 62, thereby discharging a portion of the permeate outside the system through the discharge pipe 31.
[0049] A concentration process is carried out for a predetermined period, followed by an analysis process. In the analysis process, with the water to be analyzed being supplied to the analyzer 122, the second valve 62 is closed, the first valve 60 is opened, and the third valve 64 is closed. As a result, the analyte accumulated in the membrane filtration device 16 during the concentration process is pushed out by the newly supplied water to be analyzed and sent to the flow injection system 40 as sample water via the first pipe 32. At the same time, the permeate from the membrane filtration device 16 flows out into the third pipe 36, and simultaneously, the reagent injection unit 44 is activated to supply reagents into the third pipe 36. As a result, the permeate containing reagents is supplied to the flow injection system 40 via the third pipe 36 as carrier water. At this time, the flow path of the water to be analyzed, formed by the closed second valve 62, the restricted opening of the first valve 60, and the closed third valve 64, constitutes a flushing mechanism. In this embodiment of the analyzer 122, it is preferable that the inner diameters of the first pipe 32 and the third pipe 36 are adjusted so that the concentrated water flow rate / permeate flow rate of the membrane filtration device 16 in the analysis process is in the range of 1 to 30. Furthermore, by installing a flow meter near the inlet of the first pipe 32, the detection results can be corrected using the flow meter value when the flow rates in the first pipe 32 and the third pipe 36 become similar.
[0050] Figure 4 shows an analytical apparatus 123 representing another embodiment of the present invention. In the analytical apparatus 123, reagents are continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. As shown in Figure 4, the analytical apparatus 123 has a second pipe 34 connected to the first pipe 32, instead of the bypass pipe 80 of the analytical apparatus 122 shown in Figure 3, and a third valve 64 is provided in the second pipe 34. As a result, in the concentration process, the third valve 64 is opened to send permeate water to the flow injection system 40 through the second pipe 34. In the analysis process, the third valve 64 is closed to stop the supply of permeate water, so that only the concentrated sample water of the target of analysis can be sent to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, reagents are continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the third pipe 36, making it possible to mix the reagents with the sample water.
[0051] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the second piping 34 may be connected to the upstream side of the second valve 62 of the discharge pipe 31, thereby sending a portion of the permeate from the concentration process to the second piping 34 and flowing it into the piping flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the discharge pipe 31 may be connected to the upstream side of the third valve 64 of the second piping 34 via the second valve 62, thereby discharging a portion of the permeate through the discharge pipe 31.
[0052] Next, with reference to Figure 5, we will describe the case in which the water to be analyzed is supplied in the backwashing direction of the membrane filtration device 16 during the analysis process, and the analyte is discharged from the concentration side. Figure 5 is a diagram showing an analysis device 124 of another embodiment of the present invention. In the analysis device 124, the downstream of the outlet 24 and the downstream of the discharge 26 of the membrane filtration device 16 have the same configuration as the analysis device 122 shown in Figure 3, so the same reference numerals are used for components that perform the same function, and redundant explanations are omitted.
[0053] The analyzer 124 includes a fourth pipe 38 and a fifth pipe 39. One end of the fourth pipe 38 is connected to pipe 18, and the other end is connected to the fifth pipe 39. A fourth valve 66 is also provided on the fourth pipe 38. One end of the fifth pipe 39 is connected to the discharge section 26. Permeate water can be discharged from the fifth pipe 39 to the outside of the analyzer 12. The fifth pipe 39 is also equipped with a second valve 62 downstream of the connection point with the fourth pipe 38. The pipe 18 is also equipped with a fifth valve 68 downstream of the connection point with the fourth pipe 38.
[0054] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the third pipe 36 may be connected upstream of the connection point between the fifth pipe 39 and the fourth pipe 38, thereby sending a portion of the permeate from the concentration process to the third pipe 36 and flowing it into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the fifth pipe 39 may be connected upstream of the reagent injection unit 44 of the third pipe 36 via the second valve 62, thereby discharging a portion of the permeate from the system through the fifth pipe 39.
[0055] In the analysis apparatus 124, during the concentration process, the fifth valve 68 is opened and the fourth valve 66 is closed. Then, the water to be analyzed is supplied to the membrane filtration apparatus 16 via the piping 18 by the pre-concentration pump 14. At this time, the flow of the water to be analyzed into the membrane filtration apparatus 16 is the same as in the analysis apparatus 122.
[0056] A concentration process is carried out for a predetermined period, followed by an analysis process. In the analysis process, with the water to be analyzed being supplied to the piping 18, the fifth valve 68 is closed and the fourth valve 66 is opened. The water to be analyzed supplied to the piping 18 is supplied from the piping 18 through the fourth piping 38 and the fifth piping 39, and via the discharge section 26, to the membrane filtration device 16 in the opposite direction to the flow of permeate water in the concentration process. At this time, the flow path of the water to be analyzed formed by the closed fifth valve 68 and the open fourth valve 66 constitutes the backwash mechanism. The water to be analyzed that has been shared into the membrane filtration device 16 from the discharge section 26 passes through the filtration membrane in the membrane filtration device 16, and the analytes accumulated in the membrane filtration device 16 are flowed downstream from the concentrated water outlet section 24 of the membrane filtration device 16. At this time, similar to the analysis device 122 shown in Figure 4, the first valve 60 is opened and the third valve 64 is closed, so the analytes pushed out by the water to be analyzed are sent to the flow injection system 40 as sample water via the first piping 32. In the analysis process, the permeate from the membrane filtration device 16 is sent from the water supply unit 28 through the third pipe 36 to the flow injection system 40, where reagents are added by the reagent injection unit 44. By increasing the backwash water flow rate in this way, the entire amount of endotoxin on the membrane surface of the ultrafiltration membrane can be flushed to the measurement side, thus flushing away fine particles without using hydrogen water or functional water containing chemicals. Furthermore, since there is no need to use functional water, the influence on the reactivity between endotoxin and reagents can be avoided.
[0057] Figure 6 shows an analytical apparatus 125 representing another embodiment of the present invention. The analytical apparatus 125 shown in Figure 6 differs from the analytical apparatus 124 shown in Figure 5 in that the reagent is continuously supplied to the flow injection system 40 throughout the concentration and analysis processes. Therefore, the analytical apparatus 125 shown in Figure 6 has a second pipe 34 connected to the first pipe 32 instead of the bypass pipe 80 of the analytical apparatus 124 shown in Figure 5, and a third valve 64 is provided in the second pipe 34. As a result, in the concentration process, the third valve 64 is opened to send permeate water to the flow injection system 40 through the second pipe 34. In the analysis process, the third valve 64 is closed to stop the supply of permeate water, allowing only the sample water to be supplied to the flow injection system 40. Furthermore, throughout the concentration and analysis processes, the reagent is continuously supplied from the reagent injection unit 44 to the flow injection system 40 through the third pipe 36, making it possible to mix the reagent with the sample water.
[0058] Furthermore, regarding the structure for discharging permeate from the membrane filtration device 16, there may be only one outlet for the permeate. For example, if the membrane filtration device 16 does not have a water supply unit 28 and only has a discharge unit 26 as the outlet for the permeate, the second pipe 34 may be connected upstream of the connection point between the fifth pipe 39 and the fourth pipe 38, and a portion of the permeate from the concentration process may be sent to the second pipe 34 and flowed into the flow injection system. Alternatively, if the membrane filtration device 16 does not have a discharge unit 26 and only has a water supply unit 28 as the outlet for the permeate, the fifth pipe 39 may be connected upstream of the third valve 64 of the second pipe 34 via the second valve 62, and a portion of the permeate may be discharged outside the system through the fifth pipe 39.
[0059] FIG. 7 is a graph schematically showing concentration changes of concentrated water measured by the analyzer of the present embodiment and the analyzer in the related art. The horizontal axis represents time t, and the vertical axis represents the analyte concentration C. The solid line shows the concentration change of the concentrated water measured by the analyzer 12 of the present embodiment. The broken line shows the concentration change of the analyte in sample water measured by a conventional analyzer that performs analysis while concentrating the analyte by continuously performing cross-flow filtration (see, for example, Patent Document 3).
[0060] In FIG. 7, t0 is the start time of the concentration step, t1 is the start time of the analysis step (that is, the end time of the concentration step), and t2 is the end time of the analysis step. Note that in FIG. 7, the arrival time of water from the membrane filtration device 16 to the analyzer 48 is 0 (zero), that is, the water discharged from the membrane filtration device 16 reaches the analyzer 48 immediately after being discharged.
[0061] In the analyzer 12 of the present embodiment, the concentration gradually increases from time t1, t p reaches the peak concentration C p , and then decreases toward time t2, so that the concentration peak in the analysis step is clearly observed. On the other hand, no concentration peak is observed in the analyzer of the related art. This is because, in the present embodiment, when the analyte concentrated in the membrane filtration device 16 in the concentration step is supplied to the flow injection system 40 in the analysis step, the concentration temporarily becomes high so that a peak appears, while the conventional constant cross-flow filtration method shows that the concentration change of the concentrated water is small.
[0062] In FIG. 7, a value obtained by multiplying the area of the figure surrounded by the graph between t1 and t2, the time axis, and the concentration axis by the flow rate in the analysis step indicates the number of analytes concentrated in the membrane filtration device 16 in the concentration step. From these facts, the concentration of the analyte in the analyte water can be expressed by the following formula (1).
[0063] [Equation] (In equation (1), Δt is the derivative with respect to time t, C(t) is the measured value (concentration) of the analyzer 48 at time t, R is the flow rate of the water to be analyzed supplied to the membrane filtration device 16 in the analysis process, and R0 is the flow rate of the water to be analyzed supplied to the membrane filtration device 16 in the concentration process.)
[0064] Note that Figure 7 schematically represents the concentration change; in actual analysis, the concentration is quantitatively calculated using fluorescence intensity, etc. If a sufficient number of measurement points cannot be obtained (for example, if only one data point is available, e.g., a peak value), the concentration can be determined by applying one of the following methods. One method is to measure a standard sample of known concentration in advance, create a calibration curve based on the results, and estimate the concentration by comparing it with the obtained peak value. Another method is to adjust the conditions so that the timing of endotoxin arrival at the flow injection system matches the timing of measurement by the flow injection system, and directly measure the peak value. In either method, if the supply flow rate changes, the timing of peak arrival will fluctuate, making accurate concentration estimation difficult. Therefore, it is preferable to keep the supply flow rate constant at all times. [Examples]
[0065] Next, examples will be described. The present invention is not limited to the following examples.
[0066] In this embodiment, the endotoxin concentration of the analyte water was analyzed using an analytical apparatus 12 similar to that shown in Figure 1. Endotoxin (standard endotoxin: MERCK, product number L2880) was added to water for injection to a concentration of 0.1 EU / mL (1 pM) to prepare the analyte water. Here, since the titer of 100 pg of endotoxin is generally equivalent to 1 EU, 100 EU / mL was converted to 1 nM. In the comparative example, the analysis was performed using an analytical apparatus described in Patent Document 3, which concentrates endotoxin by a conventional concentration method that performs continuous cross-flow filtration. The ultrafiltration membranes used in the examples and comparative examples had a molecular weight cutoff of 5 kDa and were made of modified polyethersulfone (MPES).
[0067] In this embodiment and comparative example, the respective flow rates are as follows: <This Embodiment> Permeate flow rate during concentration: 300 mL / min Concentrated water flow rate during analysis: 1 mL / min <Comparative Example> Concentrate water flow rate: 0.95 mL / min Permeate flow rate (reagent side): 0.95 mL / min Permeate flow rate (drainage side): 300 mL / min <Implementation Conditions> Amount of endotoxin adhering to the membrane surface: 8 × 10 -10 (g / cm 2 ) Water flow rate: 300 (mL / min) Analysis water amount: 2 (mL / min) Analysis time: 10(min) Specifications of the ultrafiltration apparatus used in Example 1 and Comparative Example 1: Ultrafiltration apparatus: Membrane area 115 cm² 2 Ultrafiltration membrane with a nominal pore size of 5 kDa (MIDIKROS manufactured by Repligen, material: modified polyethersulfone (MPES), hollow fiber membrane)
[0068] In this embodiment and comparative example, the measurement conditions were: excitation wavelength 350 nm, detection fluorescence wavelength 500 nm, fluorescent reagent Zn-dpa-C2OPy (see chemical formula (1) below), and fluorescent reagent concentration of 10 μM at the reagent injection section. The flow rate of permeate water in the concentration step of the example was 300 mL / min, and the flow rate of concentrated water in the analyzer step was 1 mL / min. [ka]
[0069] The measurement conditions for the examples and comparative examples were an excitation wavelength of 350 nm and a detection fluorescence wavelength of 500 nm.
[0070] The measurement results for the examples and comparative examples are shown in Table 1.
[0071] (Table 1) Measurement results of endotoxin (ET) concentration peaks in the examples and comparative examples. TIFF2026181643000004.tif22159
[0072] As shown in Table 1, a concentration peak as shown in Figure 7 was detected in the example. On the other hand, no concentration peak was detected in the comparative example. This indicates that in this example, the endotoxin was concentrated compared to the comparative example, and that it is possible to detect endotoxin by the flow injection system even in the low concentration range.
[0073] Table 2 below shows the relationship between the estimated concentration ratio and flux of endotoxin obtained under the following conditions for Examples a, c, and Comparative Example b.
[0074] (Implementation conditions) Example a • Using an analytical apparatus 12 similar to the one shown in Figure 1 • Analyte: ET standard solution 0.1 EU / mL • Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material: MPES (modified polyethersulfone) Filtration conditions: Total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min • Flow rate during analysis: 0.95 mL / min of concentrated water • Carrier water is ultrapure water. Flow rate: 0.95 mL / min Comparative example b • Using the analytical apparatus described in Figure 1 of Patent No. 7606197 • Analyte: ET standard solution 0.1 EU / mL • Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material: MPES (modified polyethersulfone) Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, Permeate flow rate 300mL / min, flux 27mm / min, Concentrated water flow rate 0.95mL / min • Carrier water is ultrapure water. Flow rate: 0.95 mL / min Example c ·Flux 91mm / min Other implementation conditions are the same as in Example a.
[0075] (Table 2) Estimated concentration ratio and flux TIFF2026181643000005.tif33142 *Estimated concentration ratio: This shows the relative ratio of the concentrations estimated in each example or comparative example, with the actual concentration of endotoxin contained in the water to be analyzed set to "1.00". The closer the value is to 1, the more accurately the actual concentration is reflected.
[0076] Based on the results of the series of examples and comparative examples shown in Table 2, the following findings were obtained. First, the total filtration method was shown to have a superior estimated concentration ratio compared to the conventional cross-flow filtration method. This is thought to be because endotoxins accumulated on the membrane surface are efficiently detached by backwashing or flushing.
[0077] Secondly, it is thought that when the flux is too high, the highly dispersed state of endotoxin on the membrane surface cannot be maintained, leading to a decrease in the estimated concentration ratio.
[0078] Table 3 below shows the relationship between the estimated endotoxin concentration ratio and the membrane material obtained under the following conditions for Examples (a) and (c) and Comparative Example (a). (Implementation conditions) Example (a) • Using an analytical apparatus 12 similar to the one shown in Figure 1 • Analyte: ET standard solution 0.1 EU / mL Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, membrane material: MPES (modified polyethersulfone) Filtration conditions: Total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min • Flow rate during analysis: 0.95 mL / min of concentrated water • Carrier water is ultrapure water. Flow rate: 0.95 mL / min Comparative example (i) • Using the analytical apparatus described in Figure 1 of Patent No. 7606197 • Analyte: ET standard solution 0.1 EU / mL Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, membrane material: MPES (modified polyethersulfone) Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, Permeate flow rate 300mL / min, flux 27mm / min, Concentrated water flow rate 0.95mL / min • Carrier water is ultrapure water. Flow rate: 0.95 mL / min Example (c) • Changed the material of the UF membrane to CA (cellulose acetate). Other conditions are the same as in Example (a).
[0079] (Table 3) Estimated concentration ratio and membrane material TIFF2026181643000006.tif32168
[0080] Based on the results of the series of examples and comparative examples shown in Table 3, the following findings were obtained: Compared to the cross-flow filtration method, the total filtration method showed a high estimated concentration ratio regardless of the membrane material, confirming good detection efficiency. Even under the same flow rate and flux conditions, differences in the estimated concentration ratio occurred depending on the membrane material used, suggesting that material selection is an important factor affecting analytical accuracy. In particular, MPES (modified polyethersulfone) showed the highest estimated concentration ratio and can be said to be suitable for endotoxin detection. CA (cellulose acetate) also showed a sufficient estimated concentration ratio and is considered to be a membrane material that can provide practically acceptable accuracy.
[0081] Table 4 below shows the relationship between the estimated concentration ratio and the amount of endotoxin obtained under the following conditions for Examples (k), (h), and Comparative Example (ki). (Implementation conditions) Example (ka) • Using an analytical apparatus 12 similar to the one shown in Figure 1 • Analyte: ET standard solution 0.1 EU / mL • Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material: MPES (modified polyethersulfone) Filtration conditions: Total filtration, filtration time 15 minutes, UF inlet pressure 0.16 MPa, permeate flow rate 300 mL / min, flux 27 mm / min • Flow rate during analysis: 0.95 mL / min of concentrated water • Carrier water is ultrapure water. Flow rate: 0.95 mL / min • Amount of material adhering to the film: 7 × 10 -9 g / cm 2 Comparative Example (k) • Using the analytical apparatus described in Figure 1 of Patent No. 7606197 • Analyte: ET standard solution 0.1 EU / mL • Ultrafiltration membrane: MIDIKROS, molecular weight cutoff 100 kDa, material: MPES (modified polyethersulfone) Filtration conditions: Cross-flow filtration, UF inlet pressure 0.16 MPa, Permeate flow rate 300mL / min, flux 27mm / min, Concentrated water flow rate 0.95mL / min • Carrier water is ultrapure water: flow rate 0.95 mm / min • Carrier water is ultrapure water. Flow rate: 0.95 mL / min • Amount of material adhering to the film: 6 × 10 -12 g / cm 2 Example (k) ·Permeated water flow rate 500mL / min • Amount of material adhering to the film: 9 × 10 -5 g / cm 2 Other implementation conditions are the same as in Example (k).
[0082] (Table 4) Estimated concentration ratio and amount of adhesion TIFF2026181643000007.tif22168
[0083] The following findings were obtained from the results of the series of examples and comparative examples based on Table 4. In the total filtration method, there was a tendency for a larger amount of endotoxin to adhere to the membrane surface compared to the cross-flow method. This indicates that because all of the feedwater is filtered, endotoxin tends to accumulate efficiently on the membrane surface. In addition, in example (k) where the permeate flow rate was increased, the amount of adhesion to the membrane increased significantly, suggesting that an increase in the supply flow rate affects the adhesion behavior. On the other hand, when the amount of adhesion to the membrane becomes excessive, the proportion of endotoxin that is guided out of the membrane by flushing in the analysis process decreases, and as a result, there was a tendency for the estimated concentration ratio to decrease. [Explanation of Symbols]
[0084] 12, 12A, 12B, 12C…Analytical device, 14…Pre-concentration pump, 16…Membrane filtration device, 18, 32, 34, 36, 38, 39…Piping, 20…Outer cylinder, 22…Inlet, 24…Outlet, 26…Discharge, 28…Water supply, 30…Ultrafiltration membrane, 31…Discharge pipe, 40…Flow injection system, 42…Pump, 44…Reagent injection, 46…Merger pipe, 48…Analyzer, 50…Outlet pipe, 60, 62, 64, 66, 68…Valve, 70…Loop pipe, 80…Bridge piping
Claims
1. A flow injection system that reacts the analyte with a reagent in water and analyzes the analyte using the resulting reaction product, A membrane filtration apparatus equipped with a microfiltration membrane or an ultrafiltration membrane, A concentration mechanism for accumulating the analyte in the water within the membrane filtration device, A flushing mechanism that flows the analyte accumulated in the membrane filtration device together with the concentrated water from the membrane filtration device into the flow injection system, A switching mechanism for switching between the concentration mechanism and the flushing mechanism, A reagent injection unit that supplies the reagent to the flow injection system and An analytical apparatus characterized by having the following features.
2. The analytical apparatus according to claim 1, wherein the concentration mechanism performs total filtration with the membrane filtration device.
3. The flushing mechanism flows the entire amount of water supplied to the membrane filtration device from the concentration side to the flow injection system. The analytical apparatus according to claim 1.
4. The flushing mechanism concentrates 50% or more of the water supplied to the membrane filtration device and flows it into the flow injection system. The analytical apparatus according to claim 1.
5. The permeate from the membrane filtration device is flowed from the reagent line to the flow injection system. The reagent injection unit injects the reagent into the reagent line. The analytical apparatus according to claim 4.
6. The switching mechanism alternately switches between the concentration mechanism and the flushing mechanism, enabling continuous analysis of the target of analysis. The analytical apparatus according to claim 1.
7. The flushing mechanism includes a backwashing mechanism that supplies water from the permeate side of the membrane filtration device and discharges the analyte from the concentration side of the membrane filtration device. The analytical apparatus according to claim 1.
8. The flow injection system is capable of quantitative analysis of the target of analysis. The analytical apparatus according to any one of claims 1 to 7.
9. In an analytical method for analyzing an analyte by reacting it with a reagent in water to produce a reaction product, A concentration step in which the analyte is accumulated on the filtration membrane using one or more filtration membranes selected from microfiltration membranes and ultrafiltration membranes, The analytical step involves flowing the accumulated analyte together with the concentrated water from the filtration membrane into the flow injection system, while simultaneously flowing the reagent into the flow injection system. An analytical method having the following characteristics.
10. The analytical method according to claim 9, wherein in the concentration step, the entire amount is filtered using the filtration membrane.
11. The analytical method according to claim 9, wherein the reagent is flowed through the flow injection system together with the permeate from the filtration membrane.
12. The analytical method according to claim 9, wherein in the analytical step, the entire amount of the water supplied to the filtration membrane is flowed into the flow injection system as the concentrated water.
13. The aforementioned analysis method allows for quantitative analysis of the target of analysis. The analytical method according to any one of claims 9 to 12.
14. The concentration step and the analysis step are switched alternately, allowing for continuous analysis of the target material. The analytical method according to any one of claims 9 to 12.
Citation Information
Patent Citations
Flow injection analysis
JP1987280652A
Intonation control system for voice synthesizer
JP1991002796A
Endotoxin detection method, endotoxin detection device, purified water production equipment, injection water production equipment, purified water production method, and injection water production method
JP2022011525A
Analytical device and analytical method
JP7606197B1
